SynthesisAnnals of hematology2024

Efficacy and safety of teclistamab in relapsed or refractory multiple myeloma: a systematic review and meta-analysis.

Zaheer Qureshi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.